Regulatory Reach CE marking in Europe and upcoming US launches open multi regional sales opportunities. Leverage the EU certification to partner with European distributors and target major neurovascular centers and hospitals that treat stroke.

Diversified Portfolio A diversified portfolio across neurovascular, cardiac, and peripheral thrombectomy expands the addressable market. This enables cross selling to hospitals that treat stroke, heart disease, and peripheral arterial occlusions, increasing deal size opportunities.

US Growth FDA clearance for enVast and the planned US commercial rollout create near term demand generation in US hospitals and interventional suites. Emphasize clinical training, evidence generation, and cardiovascular stroke center partnerships to accelerate adoption.

Mid Market Advantage Vesalio's mid size footprint and agility position it as an attractive partner for regional health systems and mid sized hospitals competing with larger OEMs. Opportunities include bundled equipment deals, service plans, and faster procurement cycles.

Growth Momentum Recent headquarters relocation to Plano and North Texas expansion signal growth momentum and scalable field operations. This supports rapid hiring of clinical specialists and sales coverage to penetrate key markets and build regional partnerships.